Diatos S.A. Opens Its U.S. Subsidiary in California

Diatos S.A., a privately held biopharmaceutical company, announced today the expansion of its operations with the opening of a new subsidiary, Diatos USA, Inc., with business offices located on the West Coast of the United States. Gordon M. Saul, Executive-in-Residence at InterWest Partners, has been appointed Managing Director and Chief Business Officer of Diatos USA, Inc. Diatos has been operating in the U.S. for some time, with a business representative in the San Francisco Bay Area.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-12-2005/0003386087&EDATE=)